Active Funding Opportunity Announcements (FOAs) for All NICHD

NICHD issues and participates in various FOAs to support research activities and training.

Investigator-Initiated (Unsolicited) Projects

To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.

Active FOAs for NICHD

Please note: The following FOAs are sorted by date, from most recent to oldest. Select a table heading to change how to sort and display the FOAs.

Announcement Number Sort descending Submissions Date(s) Expiration Date Activity Code(s) Title
PA-16-445 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. January 8, 2020 R01 Trophoblast Differentiation and Function (R01)
PA-17-091 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

The first standard application due date for this FOA is June 5, 2017.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
May 8, 2020 R01 Fertility Status as a Marker for Overall Health (R01)
PA-17-262 Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on . September 8, 2020 R01 Promoting NICHD Areas of Research for HIV/AIDS in Maternal and Child Health (R01)
PA-17-299 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2020 R03 Small Grants for Secondary Analyses of Existing Data Sets and Stored Biospecimens (R03)
PA-17-444 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 8, 2020 R01 Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)
PA-17-445 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 8, 2020 R03 Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)
PA-17-446 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 8, 2020 R21 Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)
PA-17-451 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 8, 2020 R03 Pregnancy in Women with Disabilities (R03)
PA-17-452 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 8, 2020 R01 Pregnancy in Women with Disabilities (R01)
PA-18-031 Multiple dates, see announcement. September 8, 2019 R01 Advancing Understanding, Prevention, and Management of Infections Transmitted from Women to their Infants (R01 Clinical Trial Optional)
PA-18-033 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 8, 2019 R01 Characterization of the Adolescent Reproductive Transition (R01 Clinical Trial Optional)
PA-18-038 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. January 8, 2020 R01 Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01 Clinical Trial Optional)
PA-18-043 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. January 8, 2020 R21 Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional)
PA-18-044 Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. January 8, 2020 R03 Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional)
PA-18-045 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 8, 2019 R21 Characterization of the Adolescent Reproductive Transition (R21 Clinical Trial Optional)
PA-18-046 Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. September 8, 2019 R03 Characterization of the Adolescent Reproductive Transition (R03 Clinical Trial Optional)
PA-18-047 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. January 8, 2020 R21 Trophoblast Differentiation and Function (R21 Clinical Trial Optional)
PA-18-048 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. January 8, 2020 R21 Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional)
PA-18-049 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

The first standard application due date for this FOA is June 16, 2017.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
May 8, 2020 R21 Fertility Status as a Marker for Overall Health (R21 Clinical Trial Optional)
PA-18-092 Multiple dates, see announcement. September 8, 2019 R21 Advancing Understanding, Prevention and Management of Infections Transmitted from Women to their Infants (R21 Clinical Trial Optional)
top of pageBACK TO TOP